Boston Medical Center, Boston University School of Medicine, Massachusetts, USA.
Boston University, Massachusetts, USA.
Psychol Psychother. 2018 Mar;91(1):42-62. doi: 10.1111/papt.12143. Epub 2017 Aug 16.
Substance use is common among adolescents with post-traumatic stress disorder (PTSD). We aimed to develop and study an integrated treatment for adolescents with co-occurring disorders.
This is a therapy development and open pilot trial study of a manualized therapy for adolescents with post-traumatic stress, depression, and substance use that uses a combination of cognitive therapy (CT) and mindfulness.
Descriptive statistics and paired sample t-tests were calculated to assess for changes in PTSD symptoms, depression, and substance use frequency from baseline to end of treatment using standardized measures and validated by urine drug screens. We also examined for safety, predictors of clinical outcomes, and treatment retention.
Thirty-seven adolescents participated in the study; 62% were study completers as defined by retention for at least 6 weeks of treatment. There were significant improvements in PTSD and depression symptoms from baseline to end of treatment, reflecting medium effect sizes, and which was associated with changes in trauma-associated cognitions. There was a reduction in cannabis use, which was the most commonly used substance.
Preliminary results suggest feasibility, safety, and potential clinical effectiveness of an integrated therapy for adolescents with PTSD, depression, and substance use. Retention was comparable to other therapy clinical trial studies of adolescents despite the high risk for poor treatment retention and poor clinical outcomes among adolescents with PTSD and co-occurring disorders. We discuss the rationale for continued research of this mindfulness-based CT for adolescents with co-occurring disorders.
Adolescents with co-occurring PTSD and substance use achieved meaningful improvement in PTSD and depression symptom severity after receiving a CT and mindfulness dual diagnosis approach. An integrated manualized therapy for dual diagnosis shows promise for reducing cannabis use in adolescents with PTSD. Changes in trauma-related cognitions have the potential to improve PTSD and depression symptoms in adolescents with substance use problems.
物质使用在患有创伤后应激障碍(PTSD)的青少年中很常见。我们旨在开发和研究一种针对共病青少年的综合治疗方法。
这是一项针对创伤后应激、抑郁和物质使用共病青少年的基于手册的治疗方法的治疗开发和开放试点试验研究,该方法结合了认知疗法(CT)和正念。
使用标准化量表和尿液药物筛查进行评估,计算描述性统计数据和配对样本 t 检验,以评估 PTSD 症状、抑郁和物质使用频率从基线到治疗结束时的变化。我们还检查了安全性、临床结果的预测因素和治疗保留率。
37 名青少年参加了这项研究;62%的人按照保留至少 6 周治疗的标准完成了研究。从基线到治疗结束时,PTSD 和抑郁症状均有显著改善,反映出中等效应大小,这与创伤相关认知的变化有关。大麻使用量减少,大麻是最常用的物质。
初步结果表明,针对 PTSD、抑郁和物质使用共病青少年的综合治疗具有可行性、安全性和潜在的临床有效性。尽管 PTSD 和共病青少年的治疗保留率差和临床结果差的风险较高,但保留率与其他青少年治疗临床试验研究相当。我们讨论了继续研究这种针对共病青少年的基于正念的 CT 的理由。
共病 PTSD 和物质使用的青少年在接受 CT 和正念双重诊断方法后,PTSD 和抑郁症状严重程度有了明显改善。针对双重诊断的综合手册治疗有望减少 PTSD 青少年的大麻使用。创伤相关认知的变化有可能改善有物质使用问题的青少年的 PTSD 和抑郁症状。